Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-05 4:13 pm Unchanged | 2023-05-05 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-05-05 4:12 pm Unchanged | 2023-05-05 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-17 5:29 pm Unchanged | 2023-04-17 | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:19 pm Unchanged | 2023-02-14 | 13G | Cogent Biosciences, Inc. COGT | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:19 pm Unchanged | 2023-02-14 | 13G | Tricida, Inc. TCDA | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:12 pm Unchanged | 2023-02-14 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:09 pm Unchanged | 2023-02-14 | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:08 pm Unchanged | 2023-02-14 | 13G | Gritstone bio, Inc. GRTS | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:05 pm Unchanged | 2023-02-14 | 13G | Chinook Therapeutics, Inc. KDNY | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:03 pm Unchanged | 2023-02-14 | 13G | Gracell Biotechnologies Inc. GRCL | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 11:58 am Unchanged | 2023-02-14 | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-23 12:17 pm Unchanged | 2023-01-23 | 13G | Theseus Pharmaceuticals, Inc. THRX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-12-30 2:15 pm Unchanged | 2022-12-30 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-10-07 2:51 pm Unchanged | 2022-10-07 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-12 1:58 pm Unchanged | 2022-09-12 | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-08 1:19 pm Unchanged | 2022-09-08 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-08-12 12:35 pm Unchanged | 2022-08-12 | 13G | Viridian Therapeutics, Inc. VRDN | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-16 12:57 pm Unchanged | 2022-05-16 | 13G | Tricida, Inc. TCDA | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-06 4:15 pm Unchanged | 2022-05-06 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-04-29 12:19 pm Unchanged | 2022-04-29 | 13G | Chinook Therapeutics, Inc. KDNY | Frazier Life Sciences Public Fund L.P. | 0 0.000% | 0 (Unchanged) | Filing |